Physicians, referrals, and the battle for volume

A cardiologist decides where a patient with chest pain gets a stent. That single decision, repeated thousands of times a year, is worth tens of millions of dollars to whichever hospital receives the patient. This is why a health system will pay a cardiologist a salary well above what their office visits alone generate. They are not buying the office visits. They are buying the referral pipelinepipelineAll active sales opportunities across the stages of the sales process, together with their combined potential value and probability of closing.View full definition →.

Welcome to the real competitive game in hospitals: controlling the doctor who directs the flow.

Why the referring physician is the strategic node

Hospitals make most of their money from a narrow set of high-margin services: cardiac procedures, orthopedic surgery (joint replacements), oncology, and complex imaging. A single knee replacement can be reimbursed in the tens of thousands of dollars in the US.

But the hospital does not choose who gets a knee replacement. The orthopedic surgeon does. And the surgeon usually gets the patient from a referring physician: a primary care doctor or a specialist upstream.

So the chain looks like this:

Primary care physician (PCP) → specialist → hospital procedure.

Whoever controls the top of that chain controls the volume at the bottom. Volume is where the margin lives, because hospitals have huge fixed costs (buildings, equipment, staff). Each additional profitable procedure spreads those fixed costs across more revenue.

The two ways to control a referral

1. Employ the physician

The dominant strategy since roughly the 2010s: hospitals directly employ doctors as salaried staff. An employed cardiologist sends their catheterization and surgery cases to their employer's hospital by default.

In the US, the share of physicians employed by hospitals or health systems (rather than in independent private practice) has risen sharply. Estimates from the American Medical Association and physician advocacy groups suggest that by the mid-2020s, well under half of physicians remained in independent practice, a major reversal from a generation earlier. (Treat the exact percentage as an estimate; it varies by specialty and source.)

2. Buy the practice

Instead of hiring individuals, systems acquire entire physician groups. This locks in an existing patient base and referral habits overnight. A large multi-site cardiology group brings its whole downstream volume with it.

Both moves answer the same question: how do we guarantee that when a doctor makes a referral decision, it points to us?

The regulatory guardrailsguardrailsRules and controls that keep an AI system inside safe, legal and on-brand boundaries, blocking outputs and actions that cross the line.View full definition →: why hospitals cannot just pay for referrals

You cannot legally pay a doctor a cash bonus for each patient they send you. Two US laws draw the line.

The Stark Law (Physician Self-Referral Law): prohibits a physician from referring Medicare patients for certain services to an entity the physician (or a family member) has a financial relationship with, unless a specific exception applies. Medicare is the US federal health program mainly for people 65 and older.

The Anti-Kickback Statute (AKS): makes it a crime to knowingly offer or receive anything of value to induce referrals for services paid by federal health programs.

This is why employment and acquisition are structured carefully. A hospital can employ a doctor and pay a market-rate salary, but that pay generally cannot be tied directly to the volume or value of referrals the doctor generates. The US Department of Justice regularly pursues hospitals that cross this line. You can read the government's plain overview at the HHS Office of Inspector General fraud site.

In Europe, the picture differs. Systems are more often publicly funded (for example the UK's NHS or France's public hospitals), so the "employ the specialist to capture referrals" dynamic is weaker where doctors are already salaried public employees. Private hospital groups (for example Ramsay Santé in France, or private providers in Germany) do compete for referring physicians, but strict anti-corruption rules and salaried public sectors dampen the US-style land grab.

The players and the balance of power

Let us mapmapUsing software to automate repetitive marketing tasks and campaigns, enabling personalisation at scale across channels like email, web, and social.View full definition → the field.

Incumbents: large integrated health systems. In the US, examples include HCA Healthcare (the largest for-profit hospital operator), nonprofit giants like Kaiser Permanente (which employs its physicians directly by design), Ascension, and CommonSpirit Health. These players have the balance sheets to employ thousands of doctors.

Challengers: two kinds.

• Private-equity-backed physician groups and specialty roll-ups that assemble independent doctors into large bargaining units. They can flip referral flows and negotiate hard.
• Outpatient and ambulatory surgery centers (ASCs): facilities where surgeries happen without an overnight stay. ASCs, often part-owned by the surgeons themselves, pull profitable procedures out of hospitals entirely.

Suppliers: here the language flips. In this chain, the physician is effectively the supplier of the raw material (the patient decision). Device makers (Medtronic, Stryker, Johnson & Johnson MedTech) and pharma are upstream suppliers to the procedure itself.

Regulators: CMS (the Centers for Medicare & Medicaid Services, which sets US payment rules), the DOJ and OIG (enforcing Stark and AKS), and the FTC (Federal Trade Commission), which reviews hospital and physician-group mergers for anti-competitive concentration.

Where power actually sits

Power flows to whoever holds the scarce, decision-making resource. The specialist who controls high-margin referrals has real leverage: they can walk to a competitor or set up their own ASC. That is why compensation for cardiologists, orthopedic surgeons, and gastroenterologists is high.

But once employed, the individual doctor's leverage drops. The system now controls the pipeline. The tension between "we need this doctor" and "we own this doctor's volume" defines the whole game.

A worked example: why employment pays

Suppose a hospital employs a cardiologist for a salary of $500,000 per year (a plausible-order figure for a US interventional cardiologist; treat as an illustrative estimate, not a quoted rate).

That cardiologist personally bills for office visits and diagnostic work: say this generates $600,000 in professional fee revenue. On its own, the doctor looks marginally profitable after overhead.

Now count the downstream. Assume the cardiologist directs 150 stent procedures per year to the hospital. If the hospital's contribution margin (revenue minus the direct variable cost) per procedure is $10,000:

150 procedures × $10,000 = $1,500,000 in downstream margin.

The office practice was never the point. The referral flow is. Even paying a premium salary, the hospital comes out far ahead because it captures the facility revenue on every procedure the doctor sends its way.

This is the entire logic of physician employment in one line: pay for the doctor, harvest the facility fees.

Competitive dynamics: how the battle plays out

The arms race

When one system employs the local orthopedic group, competitors lose that referral stream overnight. So they respond by employing their own. This is a defensive arms race: much acquisition is not about growth but about denying volume to rivals.

The ASC counterattack

Surgeons increasingly co-own ambulatory surgery centers. When a procedure moves from the hospital outpatient department to a physician-owned ASC, the surgeon captures a share of the facility margin that used to go entirely to the hospital. This is the supplier (the physician) integrating forward into the hospital's turf.

CMS has steadily expanded the list of procedures it will pay for in ASCs, which strengthens this challenger channel. The result: hospitals are fighting to keep procedures inside their walls while surgeons build the exits.

Payer pushback

Insurers (payers) also shape the flow. Through "narrow networks" (plans that only cover a limited set of providers) and prior authorization, payers can redirect where patients go, partly overriding the referring doctor. So the referral is contested by three forces: the employing system, the surgeon-owner, and the insurer.

The concentration concern

As systems employ more doctors and buy more groups, local markets concentrate. The FTC has grown more aggressive about hospital and physician-practice mergers, arguing that concentration raises prices without improving care. Antitrust enforcement is now a real constraint on the employment arms race, especially in already-concentrated metro markets.

Key Takeaways

• The referral is the strategic asset. Hospitals employ specialists and buy practices to control the doctor's referral decision, because downstream procedure volume, not the office visit, carries the margin.
• Structure is dictated by law. Stark Law and the Anti-Kickback Statute forbid paying directly for referrals, so control is achieved through salaried employment and practice acquisition, carefully priced at market rates.
• Power sits with whoever holds the scarce decision. High-margin specialists have leverage until employed; then the system captures the pipeline. Watch the surgeon-owned ASC as the counterattack that pulls margin back out.
• The US and Europe diverge. The employment land grab is a largely US phenomenon, driven by fee-for-service facility economics. Salaried public systems in Europe blunt it.
• Concentration invites regulators. The employment arms race pushes local markets toward concentration, drawing FTC antitrust scrutiny and payer countermeasures like narrow networks.